Sato Hiroyuki, Takeuchi Yoichi, Matsuda Ken, Kagaya Saeko, Saito Ayako, Fukami Hirotaka, Ojima Yoshie, Nagasawa Tasuku
Department of Nephrology, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Miyagi, Japan.
Ther Apher Dial. 2017 Aug;21(4):370-377. doi: 10.1111/1744-9987.12533. Epub 2017 Jun 30.
Neutrophil-lymphocyte ratio (NLR) is an inflammatory marker affecting the prognosis of end-stage renal disease (ESRD) patients. This study aimed to evaluate NLR levels predicting all-cause mortality in ESRD patients with diabetic nephropathy (DN), which have not been evaluated. We recruited 151 isolated DN patients who started hemodialysis between January 2009 and December 2014 at the Japanese Red Cross Ishinomaki Hospital. The primary outcomes were 1- and 3-year survival rates. The association between NLR and survival rate was evaluated using the Kaplan-Meier method and Cox proportional hazard regression analysis. Patients with an NLR ≥ 3.5 had a significantly higher mortality rate than did those with an NLR < 3.5 (log rank P = 0.02). The area under the curve (AUC) of 1-year survival for NLR was significantly larger than that for other commonly used nutritional and inflammatory variables. NLR was a more accurate predictor than other well-known markers.
中性粒细胞与淋巴细胞比值(NLR)是一种影响终末期肾病(ESRD)患者预后的炎症标志物。本研究旨在评估NLR水平对尚未得到评估的糖尿病肾病(DN)所致ESRD患者全因死亡率的预测作用。我们招募了151例2009年1月至2014年12月期间在日本红十字会石卷医院开始进行血液透析的单纯DN患者。主要结局为1年和3年生存率。采用Kaplan-Meier法和Cox比例风险回归分析评估NLR与生存率之间的关联。NLR≥3.5的患者死亡率显著高于NLR<3.5的患者(对数秩检验P=0.02)。NLR预测1年生存率的曲线下面积(AUC)显著大于其他常用的营养和炎症变量。与其他知名标志物相比,NLR是更准确的预测指标。